SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001840706-24-000011
Filing Date
2024-03-05
Accepted
2024-03-05 07:00:54
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 6-K fy2023sophiageneticssa6-k.htm 6-K 18432
2 EX-99.1 sophiageneticssaq42023.htm EX-99.1 302271
3 EX-99.2 a2023letterforshareholders.htm EX-99.2 20310
4 EX-99.3 a2023iasfinancialstatements.htm EX-99.3 1437911
5 EX-99.4 a2023sgcompensationreport.htm EX-99.4 275316
6 EX-99.5 switzerlandstatutoryfinanc.htm EX-99.5 323006
7 GRAPHIC image_0a.jpg GRAPHIC 4741
8 image_11.jpg GRAPHIC 1006356
9 image_1a.jpg GRAPHIC 6173
10 image_1b.jpg GRAPHIC 6173
11 image_2.jpg GRAPHIC 1370
12 jurgisig.jpg GRAPHIC 2932
13 picture12024.jpg GRAPHIC 245119
14 pwclogo2.jpg GRAPHIC 7150
15 pwclogo3.jpg GRAPHIC 7150
16 pwclogoa.jpg GRAPHIC 7150
17 sophlogo1.jpg GRAPHIC 22274
18 sophlogo1a.jpg GRAPHIC 22274
19 sophlogoa.jpg GRAPHIC 22274
  Complete submission text file 0001840706-24-000011.txt   4252909
Mailing Address LA PIECE, CH-1180 ROLLE V8 00000
Business Address LA PIECE, CH-1180 ROLLE V8 00000 41 21 694 10 60
SOPHiA GENETICS SA (Filer) CIK: 0001840706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40627 | Film No.: 24718236
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)